Kelly Steven
SEC insider (Form 3/4/5 filer). CIK 0001339478. Director at ARTELO BIOSCIENCES, INC. (ARTL) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jul 17, 2026. Located in SOLANA BEACH, CA.
Companies Kelly Steven has filed insider reports for
- ARTELO BIOSCIENCES, INC. (ARTL): Director
- Carisma Therapeutics Inc. (CARM): Director, Officer, President and CEO
Kelly Steven
CIK: 0001339478
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 17, 2026ARTL
ARTELO BIOSCIENCES, INC.
AwardDirectStock Option (right to buy)
136 shares- - Jan 30, 2026ARTL
ARTELO BIOSCIENCES, INC.
AwardDirectStock Options (right to buy)
292 shares- - Jan 28, 2025CARM
Carisma Therapeutics Inc.
AwardDirectStock Option (Right to Buy)
500K shares- - Dec 20, 2024ARTL
ARTELO BIOSCIENCES, INC.
AwardDirectStock Option (right to buy)
1.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 17, 2026 |  ARTL ARTELO BIOSCIENCES, INC. | Award Stock Option (right to buy) | 136 | - | - | Direct |
| Jan 30, 2026 | ARTL ARTELO BIOSCIENCES, INC. | Award Stock Options (right to buy) | 292 | - | - | Direct |
| Jan 28, 2025 |  CARM Carisma Therapeutics Inc. | Award Stock Option (Right to Buy) | 500,000 | - | - | Direct |
| Dec 20, 2024 | ARTL ARTELO BIOSCIENCES, INC. | Award Stock Option (right to buy) | 1,750 | - | - | Direct |
1-4 of 4 transactions